December 23, 2016
The Leprosy Research Initiative (LRI) is pleased to announce a call for proposals for funding commencing in 2018. The LRI exclusively funds research on leprosy or that is strongly related to leprosy and welcomes proposals for all five LRI research priorities.
Proof of concept studies of combined approaches in disease control, (prevention of) disability, rehabilitation or inclusion are needed. Preference will be given to research applications combining leprosy with other neglected tropical diseases (NTDs) or other diseases that share cross-cutting issues with leprosy. For example
- Combined self-care/wound care of leprosy and other disease affected the foot or lower limb (e.g. podoconiosis, lymphatic filariasis, diabetes)
- Combined approaches for skin-related NTDs
- Combination of prevention/treatment of NTDs
- Combination of preventive chemotherapy for leprosy and other NTDs
LRI funds in 2018 are limited, because of a large number of ongoing multi-year projects. Therefore, a project budget should not normally exceed €50,000 per year (with a maximum of four years).
Researchers interested to apply for funding by the LRI are invited to complete and submit a Letter of Intent (LoI), giving an outline of the intended research. The LoI should use the format provided on the LRI website (www.leprosyresearch.org). Applications that do not follow this format will not be considered.
A LoI may be submitted at any time during the year. However, to be considered for the budget round 2018, LoIs should be submitted by February 28th, 2017 at 24:00 (Amsterdam date and time) by email to the LRI Secretariat, c/o Ms. Nicole Dinnissen (firstname.lastname@example.org). This letter will be screened by the LRI Steering Committee (SC). If the feedback by the SC is positive, the applicants will be invited to submit a full proposal before the next deadline (June 1st, 2017).
The Leprosy Research Initiative
The Leprosy Research Initiative is a combined venture of the Netherlands Leprosy Relief (NLR), American Leprosy Missions (ALM), German Leprosy and Tuberculosis Relief Association (GLRA), effect:hope (The Leprosy Mission Canada) and The Leprosy Mission International (TLMI). Guided by an allied policy with clearly defined research priorities, the partners have established a joint fund to support leprosy research and also to establish a mechanism to access external funding. The Leprosy Mission Ireland (TLM Ireland) is supporting the running costs of the LRI. The Austrian Leprosy Relief Association (ALRA) funds a research grant.
The joint fund will be reserved for research that is exclusively or strongly related to leprosy. Additional resources will be actively sought for research in the field of general disabilities and for research aimed at different diseases (e.g. other NTDs, tuberculosis and diabetes) in combination with leprosy.